TRIS PHARMA, INC.

Description: Pharmaceutical preparations and medications, including pharmaceutical preparations and medications for the treatment of one or more central nervous system disorders, diseases, or conditions

Description: Providing information including information relating to therapeutic properties of pharmaceutical preparations; providing a website including information relating to therapeutic properties of pharmaceutical preparations.

Description: Pharmaceutical medicines and preparations containing at least an analgesic; Pain relief medications; prescription and non-prescription pharmaceutical medicines and preparations including medicines and preparations for the relief, treatment, or management of pain, pain associated with disorders, or pain associated with conditions; Distributorship of pain relief medications; distributorship of pharmaceutical medicines and preparations containing at least an analgesic; distributorship of prescription and non-prescription pharmaceutical medicines and preparations including medicines and preparations for the relief or treatment of pain, pain associated with disorders, or pain associated with conditions; Providing medical information regarding medications including containing at least an analgesic and/or a pain relief medication; Providing medical information regarding prescription and non-prescription pharmaceutical medicines and preparations including medicines and preparations for the relief, treatment, and/or management of pain, pain associated with disorders, or pain associated with conditions

Description: Pharmaceutical medicines and preparations containing at least an analgesic; Pain relief medications; prescription and non-prescription pharmaceutical medicines and preparations including medicines and preparations for the relief, treatment, or management of pain, pain associated with disorders, or pain associated with conditions; Distributorship of pain relief medications; distributorship of pharmaceutical medicines and preparations containing at least an analgesic; distributorship of prescription and non-prescription pharmaceutical medicines and preparations including medicines and preparations for the relief or treatment of pain, pain associated with disorders, or pain associated with conditions; Providing medical information regarding medications including containing at least an analgesic and/or a pain relief medication; Providing medical information regarding prescription and non-prescription pharmaceutical medicines and preparations including medicines and preparations for the relief, treatment, and/or management of pain, pain associated with disorders, or pain associated with conditions

Description: Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmaceutical preparations containing clonidine for treatment of attention deficit hyperactivity disorder; "XR"

Description: Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmaceutical preparations containing clonidine for treatment of attention deficit hyperactivity disorder

Description: Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmaceutical preparations containing clonidine for treatment of attention deficit hyperactivity disorder; "XR"

Description: Class 5: Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain
Class 44: Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations

Description: Class 5: Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain
Class 44: Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations

Description: Class 5: Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet, cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain
Class 44: Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations

Description: Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism

Description: Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses

Description: Pharmaceutical preparations which act on the central nervous system, including modified release and/or extended release compositions containing as an active pharmaceutical ingredient at least an amphetamine and/or amphetamines

Description: Pharmaceutical preparations for treating coughs, colds, allergies, and respiratory diseases, and symptoms of the same

Description: "XR"

Description: "FANNY FOAM"

Description: Pharmaceutical or medical preparations in liquid dosage form, namely, drug delivery systems comprising a drug-ion exchange resin complex for long acting or modified release or sustained release or controlled release action of the drug in the drug-ion exchange resin complex

Description: "IRON FL"

Description: Scientific research program for the development of preparations or products in liquid form that delivers contents in a short or prolonged action or sustained release or controlled release over time of up to 24 hours after swallowing for pharmaceuticals, nutraceuticals or for use in human or animal species

Description: Scientific research and development for pharmaceuticals, neutraceuticals, drug delivery products and biomedical products and raw materials and components used in pharmaceuticals; [licensing of intellectual property;] testing for others of pharmaceuticals, neutraceuticals, drug delivery products and biomedical products

Description: Vitamin and nutritional supplement